AGP Picks
View all

America Latina Times
Provided by AGP

America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 12, 2026

BingX Launches EventX, Turning Real-World Events Into Tradable Assets
May 12, 2026

BingX Launches EventX, Turning Real-World Events Into Tradable Assets

Indeterminate GlobeNewswire
Dr. Leónie H. Mattison Selected as Katherine Harvey Fellows by Leading From Within, Expanding the T.H.R.E.A.D. System™
May 12, 2026

Dr. Leónie H. Mattison Selected as Katherine Harvey Fellows by Leading From Within, Expanding the T.H.R.E.A.D. System™

Indeterminate EIN Presswire
EXCLUSIVE: Brazilian Institution Holds the World’s Largest Archive of Extraterrestrial Images
May 12, 2026

EXCLUSIVE: Brazilian Institution Holds the World’s Largest Archive of Extraterrestrial Images

Indeterminate GlobeNewswire
NEVGOLD ANNOUNCES CLOSING OF UPSIZED $42M BROKERED PRIVATE PLACEMENT FINANCING
May 12, 2026

NEVGOLD ANNOUNCES CLOSING OF UPSIZED $42M BROKERED PRIVATE PLACEMENT FINANCING

Indeterminate GlobeNewswire
Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease
May 12, 2026

Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

Indeterminate GlobeNewswire
Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress
May 12, 2026

Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire
Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias
May 12, 2026

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

Indeterminate GlobeNewswire
Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress
May 12, 2026

Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress

Indeterminate GlobeNewswire
Alpha Compute Closes $32.2 Million Revenue Contract with AI Lab Customer
May 12, 2026

Alpha Compute Closes $32.2 Million Revenue Contract with AI Lab Customer

Indeterminate GlobeNewswire
Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress
May 12, 2026

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

Indeterminate GlobeNewswire
Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026
May 12, 2026

Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026

Indeterminate GlobeNewswire
Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026

Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Cayman Airways Launches "512 to 345" Ticket Drop with Weekly Free Flights from Austin to the Cayman Islands
May 12, 2026

Cayman Airways Launches "512 to 345" Ticket Drop with Weekly Free Flights from Austin to the Cayman Islands

Indeterminate GlobeNewswire
Globex Enters Option Agreement on its Ramp/Maude Lake Gold Property in Ontario
May 12, 2026

Globex Enters Option Agreement on its Ramp/Maude Lake Gold Property in Ontario

Indeterminate GlobeNewswire
Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder
May 12, 2026

Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder

Indeterminate GlobeNewswire
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
May 12, 2026

Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027

Indeterminate GlobeNewswire
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies
May 12, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies

Indeterminate GlobeNewswire
SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform
May 12, 2026

SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform

Indeterminate GlobeNewswire
CRML Set to Become the Market Leader for Hafnium Production and Supply Security Taking Away China's Current 75% Market Share
May 12, 2026

CRML Set to Become the Market Leader for Hafnium Production and Supply Security Taking Away China's Current 75% Market Share

Indeterminate GlobeNewswire
Bitget recorta las comisiones de trading de futuros para fortalecer la liquidez en medio del auge de la tokenización
May 12, 2026

Bitget recorta las comisiones de trading de futuros para fortalecer la liquidez en medio del auge de la tokenización

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

America Latina Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.